☆ 4.7 Article

Phytoestrogen-derived multifunctional ligands for targeted therapy of breast cancer & nbsp;

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Article Chemistry, Multidisciplinary

PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases

Jiang Ni et al.

Summary: Breast cancer brain metastases (BCBM) are a major cause of morbidity and mortality among breast cancer patients because systemic drug therapy is often ineffective due to poor penetration through the blood-brain tumor barrier (BTB). This study found a nanotechnology approach that can overcome the BTB and target BCBM effectively, showing promising results in preclinical studies.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment

Naveed Ullah Khan et al.

Summary: Breast cancer brain metastases (BCBMs) are challenging due to their intracranial location and limited response to chemotherapy. Research has shown promising results with nanoparticles (NPs-K-s-A) targeting LRP1 and MMP1 to overcome the blood-brain barrier and enhance drug delivery, leading to improved therapeutic outcomes in mice with BCBMs. This fusion peptide-based drug delivery strategy shows potential for clinical management of BCBMs.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Review Pharmacology & Pharmacy

Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?

Flavio Ballante et al.

Summary: GPCRs constitute the largest family of membrane proteins in the human genome, and the increasing number of atomic-resolution structures has provided valuable insights for drug design. Structure-based virtual screening is an efficient computational approach to identify novel chemical probes from large compound libraries.

PHARMACOLOGICAL REVIEWS (2021)

Add to Collection

Review Medicine, Research & Experimental

A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment

Zhangyang Bi et al.

Summary: Tanshinone IIA and its derivatives, such as Sodium tanshinone IIA sulfonate, have demonstrated anti-inflammation, anti-oxidation, and anti-fibrosis functions in clinic. Recent studies have shown that Tanshinone IIA can mitigate fibrosis through various pathways, but contradictory and confusing results highlight the need for an accessible clinical reference. This study reviewed the pharmacological mechanisms, pharmacokinetics, and toxicology of Tanshinone IIA and its derivatives in fibrosis treatment and introduced a cutting-edge new compound formulation.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Targeting Estrogen Receptor-Positive Breast Microtumors with Endoxifen-Conjugated, Hypoxia-Sensitive Polymersomes

Babak Mamnoon et al.

Summary: Endoxifen is conjugated to polymeric nanoparticles for targeted delivery of doxorubicin to estrogen receptor-positive breast cancer cells. The developed polymersomes are hypoxia-responsive and demonstrate increased cytotoxicity and cell viability when compared to non-targeted counterparts. The use of endoxifen ligands in this novel nanoparticle design shows translational potential for ER+ breast cancer treatment.

ACS OMEGA (2021)

Add to Collection

Article Medicine, Research & Experimental

Prodrug Delivery Using Dual-Targeting Nanoparticles To Treat Breast Cancer Brain Metastases

Xiufeng Ju et al.

Summary: Brain metastases from breast cancer are difficult to surgically remove and have limited drug treatment options due to their growth patterns and the blood-brain barrier. By assembling prodrug-loaded nanoparticles that target both the BBB and metastatic breast cancer, researchers were able to significantly extend the survival time of mice with intracranial metastatic breast cancer, suggesting a potential important direction for drug therapy against brain metastases.

MOLECULAR PHARMACEUTICS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer

Huan Tang et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Add to Collection

Article Medicine, Research & Experimental

Hypoxia-Responsive, Polymeric Nanocarriers for Targeted Drug Delivery to Estrogen Receptor-Positive Breast Cancer Cell Spheroids

Babak Mamnoon et al.

MOLECULAR PHARMACEUTICS (2020)

Add to Collection

Article Chemistry, Multidisciplinary

LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases

Qian Guo et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Add to Collection

Article Pharmacology & Pharmacy

Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb Signal

Shasha Song et al.

FRONTIERS IN PHARMACOLOGY (2019)

Add to Collection

Article Nanoscience & Nanotechnology

NIR stimulus-responsive core-shell type nanoparticles based on photothermal conversion for enhanced antitumor efficacy through chemo-photothermal therapy

Kai Sun et al.

NANOTECHNOLOGY (2018)

Add to Collection

Review Pharmacology & Pharmacy

Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview

Veronica Salmaso et al.

FRONTIERS IN PHARMACOLOGY (2018)

Add to Collection

Article Chemistry, Medicinal

Tanshinone-IIA-Based Analogues of Imidazole Alkaloid Act as Potent Inhibitors To Block Breast Cancer Invasion and Metastasis in Vivo

Qiong Wu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Medicine, Research & Experimental

Molecular docking prediction and in vitro studies elucidate anti-cancer activity of phytoestrogens

Shreelekha Dutta et al.

LIFE SCIENCES (2017)

Add to Collection

Review Pharmacology & Pharmacy

Estrocen Receptor β as a Pharmaceutical Target

Margaret Warner et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2017)

Add to Collection

Article Oncology

Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils

Gabriela Vazquez Rodriguez et al.

CANCER IMMUNOLOGY RESEARCH (2017)

Add to Collection

Review Chemistry, Multidisciplinary

To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

F. Danhier

JOURNAL OF CONTROLLED RELEASE (2016)

Add to Collection

Review Chemistry, Multidisciplinary

Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications

Andreas Wicki et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Add to Collection

Article Pathology

Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms

Jia Liu et al.

PATHOLOGY RESEARCH AND PRACTICE (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association Between Hormone Receptor Expression and Epidermal Growth Factor Receptor Mutation in Patients Operated on for Non-Small Cell Lung Cancer

Hai-bo Sun et al.

ANNALS OF THORACIC SURGERY (2011)

Add to Collection

Review Medicine, Research & Experimental

Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other Diseases

Simak Ali et al.

ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)

Add to Collection

Review Chemistry, Medicinal

Breast Cancer, Estrogen Receptor and Ligands

Zhenlin Bai et al.

ARCHIV DER PHARMAZIE (2009)

Add to Collection

Article Biochemical Research Methods

Tamoxifen-Poly(ethylene glycol)-Thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer Treatment

Erik C. Dreaden et al.

BIOCONJUGATE CHEMISTRY (2009)

Add to Collection

Review Biotechnology & Applied Microbiology

Nanoparticle therapeutics: an emerging treatment modality for cancer

Mark E. Davis et al.

NATURE REVIEWS DRUG DISCOVERY (2008)

Add to Collection

Review Oncology

Implications of phytoestrogen intake for breast cancer

Christine Duffy et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2007)

Add to Collection

Article Urology & Nephrology

L-carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats

Dolrudee Boonsanit et al.

NEPHROLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.